Oncorus Inc (ONCR)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Theodore T. Ashburn
Employees:
80
4 CORPORATE DRIVE, ANDOVER, MA, 01810
857-320-6400
-
Formally known as:
- Oncorus, Inc.
Are you looking for this stock instead?
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|